Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline.
暂无分享,去创建一个
Tamara B Harris | Kristine Yaffe | Suzanne Satterfield | Eleanor M Simonsick | L. Kuller | E. Simonsick | S. Satterfield | T. Harris | K. Yaffe | S. Younkin | L. Younkin | Jingzhong Ding | N. Graff-Radford | H. Ayonayon | Hilsa N Ayonayon | Neill R Graff-Radford | Jingzhong Ding | Steven G Younkin | Andrea L. Weston | Lewis Kuller | Andrea Weston | Linda H Younkin
[1] R. Mayeux,et al. Plasma ß-amyloid and cognitive decline. , 2010, Archives of neurology.
[2] F. Jessen,et al. Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing , 2010, Experimental Neurology.
[3] Anders Wallin,et al. Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment , 2010, Neurobiology of Aging.
[4] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[5] Keith A. Johnson,et al. Cognition, Reserve, and Amyloid Deposition in Normal Aging , 2009, Annals of neurology.
[6] L. Buée,et al. Association of plasma amyloid β with risk of dementia , 2009, Neurology.
[7] L. Buée,et al. Association of plasma amyloid β with risk of dementia , 2009, Neurology.
[8] J. Becker,et al. Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study , 2008, Neurology.
[9] G. Linazasoro,et al. IMAGING β-AMYLOID BURDEN IN AGING AND DEMENTIA , 2008, Neurology.
[10] C. Jack,et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.
[11] M. Viitanen,et al. Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease , 2008, Annals of neurology.
[12] Paul Maruff,et al. β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease , 2007 .
[13] C. Rowe,et al. Imaging β-amyloid burden in aging and dementia , 2007, Neurology.
[14] R. Petersen,et al. Association of Low Plasma Aβ42/Aβ40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease , 2007 .
[15] S. Cummings,et al. Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort , 2007, Neurobiology of Aging.
[16] A. Hofman,et al. Plasma Aβ1–40 and Aβ1–42 and the risk of dementia: a prospective case-cohort study , 2006, The Lancet Neurology.
[17] J. Schneider,et al. Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.
[18] C. Mariani,et al. Plasma levels of beta-amyloid (1–42) in Alzheimer's disease and mild cognitive impairment , 2006, Neurobiology of Aging.
[19] Benjamin J. Shannon,et al. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.
[20] S. Rubin,et al. Black and White Differences in Cognitive Function Test Scores: What Explains the Difference? , 2004, Journal of the American Geriatrics Society.
[21] Yaakov Stern,et al. Cognitive reserve: Implications for diagnosis and prevention of Alzheimer’s disease , 2004, Current Neurology and Neuroscience Reports.
[22] D. DeWalt,et al. The Relationship Between Literacy and Glycemic Control in a Diabetes Disease-Management Program , 2004, The Diabetes educator.
[23] R. Mayeux,et al. Plasma A&bgr;40 and A&bgr;42 and Alzheimer’s disease: Relation to age, mortality, and risk , 2003 .
[24] J. Growdon,et al. Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid β-Protein Levels , 2003 .
[25] J. Schneider,et al. Education modifies the relation of AD pathology to level of cognitive function in older persons , 2003, Neurology.
[26] Oscar L. Lopez,et al. Risk Factors for Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.
[27] S. Younkin,et al. Serum creatinine levels correlate with plasma amyloid β protein , 2002 .
[28] Y. Stern. What is cognitive reserve? Theory and research application of the reserve concept , 2002, Journal of the International Neuropsychological Society.
[29] K Yaffe,et al. A prospective study of physical activity and cognitive decline in elderly women: women who walk. , 2001, Archives of internal medicine.
[30] H. Wiśniewski,et al. Plasma amyloid β‐peptide 1–42 and incipient Alzheimer's disease , 1999 .
[31] Eunice N. Askov,et al. Practical Assessment of Adult Literacy in Health Care , 1998, Health education & behavior : the official publication of the Society for Public Health Education.
[32] S. Younkin,et al. Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain , 1995, The Journal of Biological Chemistry.
[33] S. Younkin,et al. Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). , 1995, The Journal of biological chemistry.
[34] E. J. Mayeaux,et al. Rapid estimate of adult literacy in medicine: a shortened screening instrument. , 1993, Family medicine.
[35] H. Chui,et al. The Modified Mini-Mental State (3MS) examination. , 1987, The Journal of clinical psychiatry.
[36] L. Radloff. The CES-D Scale , 1977 .